SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Revance Therapeutics, Inc. – ‘S-3’ on 10/16/15

On:  Friday, 10/16/15, at 5:02pm ET   ·   Accession #:  1479290-15-4   ·   File #:  333-207469

Previous ‘S-3’:  ‘S-3’ on 3/4/15   ·   Next & Latest:  ‘S-3’ on 3/7/16   ·   1 Reference:  By:  SEC – ‘UPLOAD’ on 10/27/15

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

10/16/15  Revance Therapeutics, Inc.        S-3                    3:340K

Registration Statement for Securities Offered Pursuant to a Transaction   —   Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement for Securities Offered       HTML    137K 
                          Pursuant to a Transaction                              
 2: EX-5.1      Opinion re: Legality -- exhibit51                   HTML      8K 
 3: EX-23.1     Consent of Experts or Counsel -- exhibit231         HTML      5K 




        
Filing Submission 0001479290-15-000004 – SGML Text

Original SGML Text submitted by:  Revance Therapeutics, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 10:24:50.2pm ET